GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA
GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA
批准号:
8976748
负责人:
NICOLA J. CAMP
金额:
$55.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-12-01 至 2017-11-30
关键词:
AdultB-Cell LymphomasB-LymphocytesBiopsyBloodBone MarrowCaucasiansCellsChronic Lymphocytic LeukemiaClinical PathologyCollaborationsComplexComputer softwareDataDevelopmentDiagnosisDiseaseDistantElementsEpidemiologic StudiesEpidemiologyEtiologyFamilyGenesGeneticGenetic ModelsGenetic Predisposition to DiseaseGenetic ResearchGenetic RiskGenetic studyGenomeGenomic SegmentGenotypeGerm-Line MutationHaplotypesHealthHematopoietic stem cellsIndividualInternationalKnowledgeLeadLymphoblastic LeukemiaLymphoid TissueLymphomaLymphoproliferative DisordersMalignant NeoplasmsMapsMeiosisMethodsMiningMolecular GeneticsMultiple MyelomaNatureOther GeneticsPathologyPlayPositioning AttributePredispositionPublic HealthResearchResearch DesignResearch PersonnelResourcesRiskRoleSamplingShapesSingle Nucleotide PolymorphismSiteSmall-Cell LymphomaStructureSusceptibility GeneTechniquesTranslatingUnited StatesUtahVariantadult leukemiabaseblood neoplasmcancer geneticscase controlclinical decision-makingdensitydesignexperiencegenetic analysisgenetic epidemiologygenetic informationgenetic linkage analysisgenetic pedigreegenome-widegenome-wide linkagehigh riskimprovedinfancyinnovationinsightleukemialymph nodeslymphoid neoplasmmembernovelpopulation basedworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Chronic Lymphocytic Leukemia (CLL) is a B-cell lymphoproliferative disorder primarily involving the bone marrow, blood and lymph nodes. CLL is the most common type of leukemia in adults and although median survival can be quite long, between 8-12 years, most eventually succumb to their disease. The evidence for a genetic component to CLL is compelling but remains unknown, and is likely complex. However, opportunities to identify underlying variants are apparent -both by varied and unique study and analysis designs and via collaborative efforts. The research plan we propose is multifaceted, highly collaborative and includes several innovative techniques. We will pursue two study designs, each powerful to identify susceptibility genes with different underlying genetic models: high-risk pedigree-based shared genomic segment analysis and case- control association analyses. Genome-wide shared genomic segment analysis is a new method that requires extremely extended, high-risk pedigrees which are available only to researchers with genealogic resources, such as Utah. Our strategy for association will be both genome wide and candidate region. Ascertainment will involve two sites (Utah and Sheffield, UK) and will include both a discordant family-based element (Utah) and a population-based sample (UK). This approach exploits both the increased power of familial cases with the perspective of population-based samples. We are able to pursue these together due to software that we have developed. In addition to conventional analyses, we will develop new methods for the high-risk pedigree and case-control settings: homozygosity mapping in the high-risk pedigrees and case-control SGS and homozygosity mapping. Both conventional and novel methods will be performed as part of broader collaborative efforts. The resource that we will build is timely. CLL genetic research is still in its infancy. The concurrent development of these designs defines an extensive strategy for identifying regions of the genome harboring CLL susceptibility genes and will afford us the opportunity to play a significant role in shaping the direction of CLL genetic research. Particularly, Utah pedigrees, through their structure and high-risk nature, add a previously unrealized aspect to the global picture. If one design or collaborative effort can identify even a single susceptibility gene for CLL, we will have made an important and critical discovery in the etiology of CLL. Such a discovery would not only help our understanding of the etiology of CLL, but also may provide information about other lymphoproliferative disorders and may translate to other cancers.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1186/1753-6561-5-s9-s9
发表时间:
2011-11-29
期刊:
BMC proceedings
影响因子:
--
作者:
[Cai, Zheng, Knight, Stacey, Camp, Nicola J]
通讯作者:
Camp, Nicola J
DOI:
10.1158/1055-9965.epi-11-0845
发表时间:
2012-01
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
[Camp NJ, Parry M, Knight S, Abo R, Elliott G, Rigas SH, Balasubramanian SP, Reed MW, McBurney H, Latif A, Newman WG, Cannon-Albright LA, Evans DG, Cox A]
通讯作者:
Cox A
Fine-scale structure of the genome and markers used in association mapping.
基因组的精细结构和关联作图中使用的标记。
DOI:
10.1007/978-1-60327-416-6_6
发表时间:
2011
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Curtin,Karen, Camp,NicolaJ]
通讯作者:
Camp,NicolaJ
InterLymph: At the Forefront of International Lymphoma Research
-
批准号:10252007
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2020
-
负责人:NICOLA J. CAMP
-
依托单位:
NRSA Training Core
-
批准号:9889196
-
项目类别:
-
资助金额:$35.58万
-
财政年份:2018
-
负责人:NICOLA J. CAMP
-
依托单位:
Shared Genomic Segments in Multiplex Families with Gastroschisis
-
批准号:8677931
-
项目类别:
-
资助金额:$7.24万
-
财政年份:2013
-
负责人:NICOLA J. CAMP
-
依托单位:
Shared Genomic Segments in Multiplex Families with Gastroschisis
-
批准号:8509470
-
项目类别:
-
资助金额:$7.45万
-
财政年份:2013
-
负责人:NICOLA J. CAMP
-
依托单位:
Shared Genomic Segment Analysis and Tumor Subtyping in High-Risk BrCa Pedigrees
-
批准号:8676735
-
项目类别:
-
资助金额:$57.67万
-
财政年份:2012
-
负责人:NICOLA J. CAMP
-
依托单位:
Shared Genomic Segment Analysis and Tumor Subtyping in High-Risk BrCa Pedigrees
-
批准号:8371591
-
项目类别:
-
资助金额:$61.26万
-
财政年份:2012
-
负责人:NICOLA J. CAMP
-
依托单位:
Shared Genomic Segment Analysis and Tumor Subtyping in High-Risk BrCa Pedigrees
-
批准号:8517632
-
项目类别:
-
资助金额:$55.9万
-
财政年份:2012
-
负责人:NICOLA J. CAMP
-
依托单位:
Shared Genomic Segment Analysis and Tumor Subtyping in High-Risk BrCa Pedigrees
-
批准号:8848352
-
项目类别:
-
资助金额:$58.07万
-
财政年份:2012
-
负责人:NICOLA J. CAMP
-
依托单位:
Shared Genomic Segment Analysis for Localizing Multiple Myeloma Genes
-
批准号:8082654
-
项目类别:
-
资助金额:$18.92万
-
财政年份:2010
-
负责人:NICOLA J. CAMP
-
依托单位:
Shared Genomic Segment Analysis for Localizing Multiple Myeloma Genes
-
批准号:7963659
-
项目类别:
-
资助金额:$16.37万
-
财政年份:2010
-
负责人:NICOLA J. CAMP
-
依托单位:
GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA
-
批准号:7992446
-
项目类别:
-
资助金额:$53.71万
-
财政年份:2009
-
负责人:NICOLA J. CAMP
-
依托单位:
GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA
-
批准号:7781549
-
项目类别:
-
资助金额:$57.62万
-
财政年份:2009
-
负责人:NICOLA J. CAMP
-
依托单位:
GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA
-
批准号:8790427
-
项目类别:
-
资助金额:$52.56万
-
财政年份:2009
-
负责人:NICOLA J. CAMP
-
依托单位:
GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA
-
批准号:8389597
-
项目类别:
-
资助金额:$50.49万
-
财政年份:2009
-
负责人:NICOLA J. CAMP
-
依托单位:
GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA
-
批准号:8197279
-
项目类别:
-
资助金额:$55.84万
-
财政年份:2009
-
负责人:NICOLA J. CAMP
-
依托单位:
GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA
-
批准号:8585831
-
项目类别:
-
资助金额:$50.98万
-
财政年份:2009
-
负责人:NICOLA J. CAMP
-
依托单位:
Transferability of Tagging-SNPs across disease status: colon cancer and XRCC2
-
批准号:7151099
-
项目类别:
-
资助金额:$7.48万
-
财政年份:2006
-
负责人:NICOLA J. CAMP
-
依托单位:
Transferability of Tagging-SNPs across disease status: colon cancer and XRCC2
-
批准号:7286708
-
项目类别:
-
资助金额:$7.26万
-
财政年份:2006
-
负责人:NICOLA J. CAMP
-
依托单位:
GENETIC ANALYSIS TECHNIQUES FOR COMMON CANCERS
-
批准号:7254938
-
项目类别:
-
资助金额:$14.01万
-
财政年份:2004
-
负责人:NICOLA J. CAMP
-
依托单位:
GENETIC ANALYSIS TECHNIQUES FOR COMMON CANCERS
-
批准号:7471445
-
项目类别:
-
资助金额:$14.01万
-
财政年份:2004
-
负责人:NICOLA J. CAMP
-
依托单位:
海外基金